Crossmark

Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins

Crossref DOI link: https://doi.org/10.1007/s00018-018-2773-4

Published Online: 2018-02-13

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Karimi, Nasibeh

Cvjetkovic, Aleksander

Jang, Su Chul

Crescitelli, Rossella

Hosseinpour Feizi, Mohammad Ali

Nieuwland, Rienk

Lötvall, Jan

Lässer, Cecilia http://orcid.org/0000-0003-1279-1746
Funding

Funding for this research was provided by:

Vetenskapsrådet (K2014-85X-22504-01-3)

Cancerfonden (CAN2014/844)

VBG Group Herman Krefting Foundation for Asthma and Allergy Research

Hjärt-Lungfonden (20150588)
License Information

Text and Data Mining valid from 2018-02-13
More Information

Article History

Received: 2 November 2017

Revised: 3 January 2018

Accepted: 1 February 2018

First Online: 13 February 2018

Compliance with ethical standards

:

: JL and SCJ have written several patents in the field of extracellular vesicles as therapeutics and are currently or have previously been employees of Codiak BioSciences Inc. CL and AC are co-inventors on a patent using extracellular vesicles as diagnostic tools in diseases. The other authors declare that there are no financial, personal, or professional interests that could be construed to have influenced the paper.